Jasmina Nikodinović-Runić

Dr. Jasmina Nikodinović-Runić


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in Cellulose
Verified
Journal Article
Closed access
PDF file
Ana KramarAna Kramar
Ana Kramar
TITatjana Ilic-Tomic
Tatjana Ilic-Tomic
Jelena LadjarevićJelena Ladjarević
Jelena Ladjarević
JNJasmina Nikodinović-Runić
Jasmina Nikodinović-Runić
Mirjana KosticMirjana Kostic
Mirjana Kostic

2 September 2022
Verified
Conference Paper
Closed access
Olivia SolimanOlivia Soliman
Olivia Soliman
PFPablo Ferrero
Pablo Ferrero
MGMiguel Valera Gómez
Miguel Valera Gómez
IAIvana Aleksic
Ivana Aleksic
Muhammad AzeemMuhammad Azeem
Muhammad Azeem
MFMargaret E. Brennan Fournet
Margaret E. Brennan Fournet

2 September 2022
Verified
Conference Paper
Closed access
Olivia SolimanOlivia Soliman
Olivia Soliman
PFPablo Ferrero
Pablo Ferrero
MGMiguel Valera Gómez
Miguel Valera Gómez
IAIvana Aleksic
Ivana Aleksic
Muhammad AzeemMuhammad Azeem
Muhammad Azeem
MFMargaret E. Brennan Fournet
Margaret E. Brennan Fournet

2 September 2022
Verified
Conference Paper
Closed access
Olivia SolimanOlivia Soliman
Olivia Soliman
PFPablo Ferrero
Pablo Ferrero
MGMiguel Valera Gómez
Miguel Valera Gómez
IAIvana Aleksic
Ivana Aleksic
Muhammad AzeemMuhammad Azeem
Muhammad Azeem
MFMargaret E. Brennan Fournet
Margaret E. Brennan Fournet

1 November 2022 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Nevena StevanovićNevena Stevanović
Nevena Stevanović
Jelena SimićJelena Simić
Jelena Simić
JKJakob Kljun
Jakob Kljun
MSMia Stankovic
Mia Stankovic
JNJasmina Nikodinović-Runić
Jasmina Nikodinović-Runić
Biljana GlišićBiljana Glišić
Biljana Glišić
Recently, we synthesized silver(I) complex with the antifungal agent itraconazole, which showed improved anti-Candida potential and therapeutic safety in comparison to itraconazole and rescued zebrafish embryos affected by lethal C. albicans infection, when used in safe doses. Inspired by these results, in the present study, three new silver(I) complexes with clinically used azoles, econazole (ecz), clotrimazole (ctz) and voriconazole (vcz), [Ag(ecz)2]SbF6 (Ag1), [Ag(ctz)2]SbF6 (Ag2) and {[Ag(vcz)2]SbF6}n (Ag3) were synthesized and structurally characterized by elemental microanalysis, mass spectrometry, spectroscopy (1H NMR, IR and UV-Vis), cyclic voltammetry, molar conductivity measurements, and single crystal X-ray diffraction analysis. The spectroscopic and crystallographic results revealed that, in the synthesized silver(I) complexes, azole ligands are monodentately coordinated to the Ag(I) ion through the nitrogen atom forming [Ag(azole)2]+ complex cation. The antimicrobial effect of complexes and azole ligands was evaluated against different Candida species, as well as Gram-positive and Gram-negative bacteria. The synthesized complexes Ag1-3 exhibited good to moderate antimicrobial activity being, in most cases, more active than the corresponding azole ligands. Complexes Ag2 and Ag3 also showed strong inhibitory activity against C. albicans biofilm formation and strong inhibition of C. albicans filamentation at subinhibitory concentrations.

2 September 2022
Verified
Conference Paper
Closed access
Olivia SolimanOlivia Soliman
Olivia Soliman
PFPablo Ferrero
Pablo Ferrero
MGMiguel Valera Gómez
Miguel Valera Gómez
IAIvana Aleksic
Ivana Aleksic
Muhammad AzeemMuhammad Azeem
Muhammad Azeem
MFMargaret E. Brennan Fournet
Margaret E. Brennan Fournet